This May Be Democrats’ Best Chance to Lower Drug Prices
For patients with certain cancers, out-of-pocket spending can exceed $15,000 a year. Legislation could take aim at prices and the amounts Medicare patients are charged.
What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Children
Once the experts weigh in, the Food and Drug Administration itself makes a decision and then a similar process happens at the Centers for Disease Control and Prevention.
Biden and Democrats Push for Budget Deal This Week as Rifts Remain
Negotiators were closing in on a deal that could spend around $1.75 trillion, but lawmakers were still haggling over critical disagreements on the sprawling social policy bill.
Pfizer Says Its Vaccine Is Highly Protective in Children 5 to 11
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps next week, a long-awaited development that would affect 28 million children.
Here’s Why Developing Countries Can Make the Top Covid Vaccines
Pfizer and Moderna are skeptical, but we found 10 companies in Africa, Asia and South America well-positioned to produce the gold-standard mRNA shots.
Pfizer says new data show booster shots of its vaccine are highly protective against Covid.
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.
Iran Plans to Abandon One of Its Homegrown Covid Shots
The defense ministry said there was too little demand for its Fakhravac vaccine to justify producing it, and blamed the health ministry for reneging on promised orders.
Why Is Good Medical Advice for Pregnant Women So Hard to Find?
A recent warning about the pain reliever acetaminophen is a reminder that health risks in pregnancy remain maddeningly, dangerously understudied.
Democrats’ Campaign to Control Drug Prices Nears Collapse
Democrats have made giving government the power to negotiate drug prices a central campaign theme for decades. With the power to make it happen, they may fall short yet again.
Qué pasa si combino vacunas en la dosis de refuerzo
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que respalda la medida.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.